Literature DB >> 11056832

Olanzapine for nightmares and sleep disturbance in posttraumatic stress disorder (PTSD)

L A Labbate, S Douglas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11056832

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  6 in total

1.  Pharmacotherapy of treatment-resistant combat-related posttraumatic stress disorder with psychotic features.

Authors:  Nela Pivac; Dragica Kozarić-Kovacić
Journal:  Croat Med J       Date:  2006-06       Impact factor: 1.351

2.  Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters.

Authors:  Seth D Norrholm; Tanja Jovanovic
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

3.  Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder.

Authors:  Nela Pivac; Dragica Kozaric-Kovacic; Dorotea Muck-Seler
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

4.  Chronic Sleep Disruption and the Reexperiencing Cluster of Posttraumatic Stress Disorder Symptoms Are Improved by Olanzapine: Brief Review of the Literature and a Case-Based Series.

Authors:  James H. States; Clarke D. St Dennis
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2003-04

5.  Psychopharmacotherapy of posttraumatic stress disorder.

Authors:  Dragica Kozaric-Kovacic
Journal:  Croat Med J       Date:  2008-08       Impact factor: 1.351

6.  Off-label indications for atypical antipsychotics: A systematic review.

Authors:  Konstantinos N Fountoulakis; Ioannis Nimatoudis; Apostolos Iacovides; George Kaprinis
Journal:  Ann Gen Hosp Psychiatry       Date:  2004-02-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.